BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease

BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease: Pilot Study

The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.

Inclusion Criteria:

• Age 19 and more
• Vasospastic angina diagnosed by provocation test including ergonovine provocation coronary angiography or ergonovine echocardiogram
• No-ischemia producing moderate coronary artery disease(stenosis>50%, FFR>0.8)

Exclusion Criteria:

• Ischemic coronary lesion
• Organic heart disease associated with myocardial ischemia or sudden cardiac death
• History of percutaneous coronary intervention
• Cerebrovascular diseases or peripheral disease
• NYHA III and IV
• Cardiac pacemaker or implantable defibrillator
• Pregnancy or breast feeding
• Life expectancy less than 2 years